Associate Director, Tax
Revolution Medicines - Redwood City, California, United States
Posted May 12, 2026
Benefits
- Parental leave
- Not verified
- Non-birth-parent leave
- Not verified
- Family-building benefits
-
- Fertility benefits: Not verified
- Adoption assistance: Not verified
- Surrogacy assistance: Not verified
- Mental health support
- Not verified
- Relocation assistance
- Not verified
- Childcare support
- Not verified
- Learning budget
- Not verified
- Verification
- Not verified
- Salary
- $186K-$233K not verified - source not recorded; timestamp not recorded
- 401(k) match
- Not verified
Was this benefit information wrong? Tell us.
Market context
- U.S. role benchmark (BLS OEWS)
- $106,409 U.S. median for this role
- Projected growth (BLS Employment Projections)
- +7.7% - Faster than average
97% above the BLS role benchmark for finance aggregate.
Matched to SOC 13-2011 - Finance aggregate by role bucket.
Source: U.S. Bureau of Labor Statistics, OEWS, May 2024 and Employment Projections, 2024-2034.
Schedule
- Shift type
- Not verified
- Weekend work
- Not verified
Application
- Cover letter
- Not verified
- Assessment
- Not verified
- Deadline
- Not stated
Where they hire
State eligibility is not yet verified.
About this role
Associate Director, Tax Redwood City, California, United States Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: Revolution Medicines is seeking a motivated individual with a tax background to play a critical role as a Associate Director of Tax within the finance department. Partnering with the Senior Director of Tax and finance team, the Associate Director will support global tax strategy, provision, and compliance, acting as a key cross-functional collaborative partner with R&D, international, and commercial teams to achieve business goals and meet the financial obligations of the organization. The role is an individual contributor reporting to the Senior Director of Tax and will work closely with external tax advisors, auditors, and internal stakeholders. Current tax department of two, with the possibility of expanding the team as the company advances. Responsibilities include: - Assist in the management and development of Company's international, US and state tax strategy. - Assist with and/or drive the research of complex tax technical topics, ultimately positioning
Read the full description at www.revmed.com. FewerJobs shows a preview and links to the original posting.
Apply link not verified; last-live date unavailable.
What verified means
Verified means a displayed claim has recorded source fields, a user-resolvable source, and a full check date.
Related jobs
-
Principal Project Management
Northrop Grumman - United States-California-San Diego
-
Deployable Principal / Sr Principal Logistics Management Analyst - Top Secret
Northrop Grumman - United States-California-Palmdale
-
Sr. Director of Workday & Financial Systems
Onterris INC - USA-Remote
-
IMS OU Sr Principal Property and Asset Management Analyst
Northrop Grumman - United States-Oklahoma-Oklahoma City